Pelacarsen and Cardiovascular Outcomes in Patients with High Lipoprotein(a)
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
Authors: Leslie Cho, Stephen J. Nicholls, Seth Frndak, Kathy Wolski, Børge G. Nordestgaard, Brian Manning, Eran Leitersdorf, Ulf Landmesser, Venu Menon, Jackie McCluskey, Michael J. Blaha, Ryuichi Morishita, A. Michael Lincoff, Ziqiang Zhao, Jing Wang, Raul D. Santos, Ioanna Gouni-Berthold, Sotirios Tsimikas, Anastasia Lesogor, Hui Cao, Steven E. Nissen
Institutions: Cleveland Clinic, Monash University, University of Copenhagen, Herlev Hospital, Copenhagen University Hospital, Gentofte Hospital, Hebrew University of Jerusalem, Deutsches Herzzentrum der Charité, Charité – Universitätsmedizin Berlin, Johns Hopkins University, Johns Hopkins Medicine, Johns Hopkins Hospital, Center of Medical Innovation and Translational Research, The University of Osaka, The University of Osaka, Hospital Israelita Albert Einstein, University of Cologne, University of California San Diego
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Novartis
OpenAlex ID: W7225454656